Coleman, R. L., Ports, K., Gradinariu, V., Gerome, D., Miao, M., Girvan, A., Pailden, J., Kamalakar, R., Zagadailov, E., Diver, E., Stec, J. J., Jain, R. (2025). Efficacy of third-line and later (3L+) therapies post poly (ADP-ribose) polymerase inhibitor (PARPi) exposure in recurrent platinum-sensitive ovarian cancer (PSOC): A pooled clinical trial database analysis.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.5579